274 related articles for article (PubMed ID: 16730704)
1. Involvement of spinal mu1-opioid receptors on the Tyr-d-Arg-Phe-sarcosine-induced antinociception.
Mizoguchi H; Nakayama D; Watanabe H; Ito K; Sakurada W; Sawai T; Fujimura T; Sato T; Sakurada T; Sakurada S
Eur J Pharmacol; 2006 Jul; 540(1-3):67-72. PubMed ID: 16730704
[TBL] [Abstract][Full Text] [Related]
2. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
3. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
[TBL] [Abstract][Full Text] [Related]
4. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.
Mizoguchi H; Kon-No T; Watanabe H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
Peptides; 2013 Dec; 50():139-44. PubMed ID: 24126280
[TBL] [Abstract][Full Text] [Related]
5. Involvement of multiple µ-opioid receptor subtypes on the presynaptic or postsynaptic inhibition of spinal pain transmission.
Mizoguchi H; Takagi H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
Peptides; 2014 Jan; 51():15-25. PubMed ID: 24512946
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2.
Mizoguchi H; Watanabe H; Hayashi T; Sakurada W; Sawai T; Fujimura T; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2006 Apr; 317(1):362-8. PubMed ID: 16394196
[TBL] [Abstract][Full Text] [Related]
7. Contribution of spinal mu(1)-opioid receptors and dynorphin B to the antinociception induced by Tyr-d-Arg-Phe-Sar.
Mizoguchi H; Ito K; Watanabe H; Watanabe C; Katsuyama S; Fujimura T; Sakurada T; Sakurada S
Peptides; 2006 Nov; 27(11):2786-93. PubMed ID: 16919848
[TBL] [Abstract][Full Text] [Related]
8. Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Nagase H; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2001 Aug; 298(2):592-7. PubMed ID: 11454920
[TBL] [Abstract][Full Text] [Related]
9. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
10. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
Gergen KA; Zadina JE; Paul D
Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
[TBL] [Abstract][Full Text] [Related]
11. Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of mu-opioid receptor clone leads to differential loss of spinal endomorphin-1-and endomorphin-2-induced antinociception in the mouse.
Wu HE; Mizoguchi H; Terashvili M; Leitermann RJ; Hung KC; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2002 Nov; 303(2):867-73. PubMed ID: 12388674
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibitory effects of mu-opioids on substance P- and capsaicin-induced nociceptive behavior in mice.
Watanabe H; Nakayama D; Yuhki M; Sawai T; Sakurada W; Katsuyama S; Hayashi T; Watanabe C; Mizoguchi H; Fujimura T; Sakurada T; Sakurada S
Peptides; 2006 Apr; 27(4):760-8. PubMed ID: 16226344
[TBL] [Abstract][Full Text] [Related]
13. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse.
Jinsmaa Y; Fujita Y; Shiotani K; Miyazaki A; Li T; Tsuda Y; Okada Y; Ambo A; Sasaki Y; Bryant SD; Lazarus LH
Eur J Pharmacol; 2005 Feb; 509(1):37-42. PubMed ID: 15713427
[TBL] [Abstract][Full Text] [Related]
15. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception.
Sakurada S; Zadina JE; Kastin AJ; Katsuyama S; Fujimura T; Murayama K; Yuki M; Ueda H; Sakurada T
Eur J Pharmacol; 1999 May; 372(1):25-30. PubMed ID: 10374711
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
Gergen KA; Zadina JE; Kastin AJ; Paul D
Eur J Pharmacol; 1996 Mar; 298(3):235-9. PubMed ID: 8846821
[TBL] [Abstract][Full Text] [Related]
18. The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.
Xie H; Woods JH; Traynor JR; Ko MC
Anesth Analg; 2008 Jun; 106(6):1873-81. PubMed ID: 18499626
[TBL] [Abstract][Full Text] [Related]
19. Involvement of endogenous opioid peptides in the antinociception induced by the novel dermorphin tetrapeptide analog amidino-TAPA.
Mizoguchi H; Watanabe C; Watanabe H; Moriyama K; Sato B; Ohwada K; Yonezawa A; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Apr; 560(2-3):150-9. PubMed ID: 17307162
[TBL] [Abstract][Full Text] [Related]
20. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
